Shares of Protalix (PLX) +4.4% premarket after a report says the firm will file a request with the FDA within days for approval of the firm's Gaucher's disease treatment Uplyso.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs